Long non-coding RNA expression profile in human gastric cancer and its clinical significances

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Song, Haojun ^a   Sun, Weiliang ^a   Ye, Guoliang ^a   Ding, Xiaoyun ^a   Liu, Zhong ^a   Zhang, Sijie ^a   Xia, Tian ^a   Xiao, Bingxiu ^a   Xi, Yang ^a   Guo, Junming ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Expression profile; Gastric cancer; H19; Long non coding RNA; uc001lsz

Indexed keywords

LONG UNTRANSLATED RNA;

ADULT; ARTICLE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; LUNG CANCER; MALE; MICROARRAY ANALYSIS; PRECANCER; PROSTATE CANCER; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; CLUSTER ANALYSIS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; RNA, LONG NONCODING; ROC CURVE; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84884478811     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-225     Document Type: Article

References (35)

1. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
2. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009, 10:155-159. 10.1038/nrg2521, 19188922.
3. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011, 21:354-361. 10.1016/j.tcb.2011.04.001, 21550244.
4. Klecka J, Holubec L, Pesta M, Topolcan O, Hora M, Eret V, Finek J, Chottova-Dvorakova M, Babjuk M, Novak K, Stolz J. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis. Anticancer Res 2010, 30:665-670.
5. Shen M, Chen W, Yu K, Chen Z, Zhou W, Lin X, Weng Z, Li C, Wu X, Tao Z. The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population. Exp Mol Pathol 2011, 90:97-100. 10.1016/j.yexmp.2010.10.009, 20970419.
6. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041. 10.1038/sj.onc.1206928, 12970751.
7. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26:851-858. 10.1038/sj.onc.1209846, 16878148.
8. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, WU LM, Chen LM, Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012, 29:1810-1816. 10.1007/s12032-011-0004-z, 21678027.
9. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076. 10.1038/nature08975, 3049919, 20393566.
10. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011, 71:6320-6326. 10.1158/0008-5472.CAN-11-1021, 21862635.
11. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002, 70:604-611. 10.1086/338934, 384940, 11813134.
12. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009, 24:652-657. 10.1111/j.1440-1746.2008.05666.x, 19175831.
13. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 2010, 88:709-717.
14. Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, Zhang A, Jia Z, Wang G, Yu S, Pu P, Dong L, Kang C. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol 2012, 40:2004-2012.
15. Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D, Zhang Y. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 2010, 45:17-23. 10.1007/s00535-009-0135-6, 19802518.
16. Mei D, Song H, Wang K, Lou Y, Sun W, Liu Z, Ding X, Guo J. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol 2013, 30:709.
17. Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, Xiao B, Guo J. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumour Biol 2013, DOI 10.1007/s13277-013-0821-0.
18. Khachane AN, Harrison PM. Mining mammalian transcript data for functional long non-coding RNAs. PLoS ONE 2010, 5:e10316. 10.1371/journal.pone.0010316, 2859052, 20428234.
19. Oliva J, Bardag-Gorce F, French BA, Li J, French SW. The regulation of non-coding RNA expression in the liver of mice fed DDC. Exp Mol Pathol 2009, 87:12-9. 10.1016/j.yexmp.2009.03.006, 2885145, 19362547.
20. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007, 2:e84.
21. Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 2011, 39:2119-2128. 10.1177/147323001103900608, 22289527.
22. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M, Zatloukal K. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132:330-342. 10.1053/j.gastro.2006.08.026, 17241883.
23. Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol 2009, 21:688-692. 10.1097/MEG.0b013e328306a3a2, 19445043.
24. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki Y, Nishida T, Bamba T, Kanda T, Ajioka Y, Taguchi T, Okahara S, Takahashi H, Nishida Y, Hosokawa M, Hasegawa T, Tokino T, Hirata K, Imai K, Toyota M, Shinomura Y. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012, 72:1126-1136. 10.1158/0008-5472.CAN-11-1803, 22258453.
25. Cheng Y, Jin Z, Agarwal R, Ma K, Yang J, Ibrahim S, Olaru AV, David S, Ashktorab H, Smoot DT, Duncan MD, Hutcheon DF, Abraham JM, Meltzer SJ, Mori Y. LARP7 is a potential tumor suppressor gene in gastric cancer. Lab Inves 2012, 92:1013-1019.
26. Lu Y, Lu P, Zhu Z, Xu H, Zhu X. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer. J Exp Clin Cancer Res 2009, 28:125. 10.1186/1756-9966-28-125, 2753348, 19737423.
27. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012, 279:3159-3165. 10.1111/j.1742-4658.2012.08694.x, 22776265.
28. Cao WJ, Wu HL, He BS, Zhang YS, Zhang ZY. Analysis of long non-coding RNA expression profiles in gastric cancer. World J Gastroenterol 2013, 19:3658-3664. 10.3748/wjg.v19.i23.3658, 3691033, 23801869.
29. Dinger ME, Amaral PP, Mercer TR, Pang KC, Bruce SJ, Gardiner BB, Askarian-Amiri ME, Ru K, Solda G, Simons C, Sunkin SM, Crowe ML, Grimmond SM, Perkins AC, Mattick JS. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res 2008, 18:1433-1445. 10.1101/gr.078378.108, 2527704, 18562676.
30. Pang KC, Dinger ME, Mercer TR, Malquori L, Grimmond SM, Chen W, Mattick JS. Genome-wide identification of long noncoding RNAs in CD8+ T cells. J Immunol 2009, 182:7738-7748. 10.4049/jimmunol.0900603, 19494298.
31. Mazar J, Sinha S, Dinger ME, Mattick JS, Perera RJ. Protein-coding and non-coding gene expression analysis in differentiating human keratinocytes using a three-dimensional epidermal equivalent. Mol Genet Genomics 2010, 284:1-9. 10.1007/s00438-010-0543-6, 20499100.
32. Hall PA, Russell SH. New perspectives on neoplasia and the RNA world. Hematol Oncol 2005, 23:49-53. 10.1002/hon.748, 16216032.
33. Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, Colnot S, Godard C, Terris B, Jammes H, Dandolo L. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 2008, 105:12417-12422. 10.1073/pnas.0801540105, 2527926, 18719115.
34. Allen A, Hutton DA, Pearson JP. The MUC2 gene product: a human intestinal mucin. Int J Biochem Cell Biol 1998, 30:797-801. 10.1016/S1357-2725(98)00028-4, 9722984.
35. Khattab AZ, Nasif WA, Lotfy M. MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis. Med Oncol 2011, 28:S207-S213.